{
  "ptid_time": "127_S_5185_2013-08-27",
  "img_path": "/data/qiuhui/data/adni/images/127_S_5185/2013-08-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 26,322 mm³, 17.8% above the reference mean. With a Z-score of 0.45 (67.2th percentile), this represents normal volume ; hippocampal volume measures 7,248 mm³, 5.7% below the reference mean. With a Z-score of -0.64 (26.2th percentile), this represents normal volume ; whole brain volume measures 1,130,300 mm³, 9.8% above the reference mean. With a Z-score of 1.22 (88.9th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,162 mm³, 6.9% above the reference mean. With a Z-score of 0.54 (70.4th percentile), this represents normal volume ; fusiform gyrus volume measures 19,470 mm³, 6.9% above the reference mean. With a Z-score of 0.78 (78.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,386 mm³, 0.7% below the reference mean. With a Z-score of -0.06 (47.7th percentile), this represents normal volume . ",
  "text_data": "Age is 69.9 years. Gender is Female. Education: 20 years. Handedness: Left. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 30.0. MoCA: 30.0. Logical Memory: 14.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.19 SUVR (normal ); Amyloid beta: 662.80 pg/mL (normal ); Total tau: 448.30 pg/mL (significant elevated); Phosphorylated tau: 45.64 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within normal ranges, with only mild hippocampal volume reduction (-0.64 Z-score). However, the CSF biomarkers show **elevated T-tau and profound P-tau**, which strongly suggest Alzheimer's pathology despite normal Aβ and AV45 (amyloid PET). The preserved cognitive scores (MMSE 30, MoCA 30) indicate no functional impairment.  \n\n**Diagnosis:** **MCI (due to Alzheimer’s pathology)**  \n**Confidence:** **Medium** (Biomarkers strongly support AD, but cognitive performance remains intact, making this likely prodromal AD/MCI rather than dementia.)  \n\n*Note: The discrepancy between normal Aβ/PET and elevated tau may suggest non-amyloid tauopathy (e.g., primary age-related tauopathy, PART), but the P-tau elevation is more typical of AD. Clinical follow-up is needed to track cognitive decline.*",
  "timestamp": "2025-07-26T13:27:15.562401"
}